Back to Trades
Booth Andrew
Chief Financial OfficerCIK 0001834411
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 2 filings between 2026, Booth Andrew, Chief Financial Officer, has disclosed $2.9M in transactions — all concentrated in AbCellera Biologics Inc. (ABCL). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Jun 3 | ABCL AbCellera Biologics Inc. | Booth Andrew | Chief Financial Officer | Exercise | $95.0K |
| Jan 5 | ABCL AbCellera Biologics Inc. | Booth Andrew | Chief Financial Officer | Award | $2.8M |
2 filings